Practical Oncologist Family of Sites
- 2014-08-25 - Switch from imatinib to nilotinib improved outcomes in chronic phase CML
- 2014-08-25 - Gemtuzumab-Ozogamicin Improves EFS in Young AML Patients
- 2014-08-25 - PET/CT after one chemotherapy cycle highly prognostic in Hodgkin’s lymphoma
- 2014-08-25 - Mirati Therapeutics Receives Orphan Designation from U.S. Food & Drug Administration for Mocetinostat in Diffuse Large B-Cell Lymphoma
- 2014-08-25 - Avillion Doses First Patients in Leukemia Drug Trial
- 2014-08-11 - ASH to Host Agenda-Setting Scientific Meeting on Lymphoma Biology
- 2014-08-06 - Cancer Genetics, Inc. Releases the Only Comprehensive Genomic Test to Diagnose & Stratify the Most Common Form of Leukemia (CLL)
- 2014-08-06 - Weakness of leukemic stem cells discovered
- 2014-08-04 - FDA drug approvals-August 2014
- 2014-07-31 - Imbruvica Approved for Chronic Lymphocytic Leukemia
- 2014-07-30 - Stemline Therapeutics Announces Opening of SL-401 Corporate IND and Start of Clinical Trials in BPDCN and AML
- 2014-07-30 - Lorus Therapeutics Receives FDA Clearance of IND to Initiate LOR-253 Clinical Program in Patients with AML, MDS and other Blood Cancers
- 2014-07-30 - FDA expands approved use of Imbruvica for chronic lymphocytic leukemia
- 2014-07-30 - European CHMP adopts positive opinion for Gilead’s Zydelig to treat chronic lymphocytic leukemia and follicular lymphoma
- 2014-07-30 - MorphoSys updates its proprietary portfolio including clinical programmes MOR208, MOR103 & MOR202